iTeos Therapeutics will set aside inupadenant following lackluster mid-stage data in non-small cell lung cancer. The company will focus on its TIGIT therapies instead, with …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
California biotech Allakos said it would end development of its lead inflammatory disease program and lay off half of its workforce to save costs. The
A Washington D.C. district court judge denied an emergency motion to restore score validity for 832 Nepali medical graduates whose U.S. Medical Licensing Examination (USMLE)
What You Should Know: – Sonio, a medtech company dedicated to women’s and children’s health, announced today that it has received CE marking for its